Company Filing History:
1 out of 832,891 Years Active: 2007
Title: Martin Wurm: Innovator in Growth-Regulating Factors
Introduction
Martin Wurm is a notable inventor based in Innsbruck, Austria. He has made significant contributions to the field of biomedical research, particularly in understanding the behavior of immune cells through the release of growth-regulating factors from endothelial cells. His innovative work has implications for various therapeutic applications.
Latest Patents
Martin Wurm holds a patent for a process and substances that facilitate the release of a growth-regulating factor from endothelial cells. This patent describes how endothelial cells can release soluble factors that alter immune cell behavior. Specifically, the release of these factors promotes the proliferation of resting and weakly activated lymphocytes while inhibiting the proliferation of highly activated lymphocytes and transformed lymphoblasts. This process is induced by the administration of pentacyclic oxindole alkaloids and inhibited by tetracyclic oxindole alkaloids.
Career Highlights
Throughout his career, Martin Wurm has worked with various organizations, including Immodal Pharmaka Gesellschaft M.b.h. His research has focused on the intricate interactions between endothelial cells and immune responses, contributing to a deeper understanding of cellular behavior in the immune system.
Collaborations
Martin has collaborated with notable colleagues such as Klaus Keplinger and Gerhard Laus. These partnerships have enriched his research and expanded the impact of his findings in the scientific community.
Conclusion
Martin Wurm's innovative work in the field of growth-regulating factors showcases his dedication to advancing biomedical research. His contributions have the potential to influence therapeutic strategies in immunology and beyond.